Skip to content
DataLookout
Menu

NCT07692984

The Effect of Comorbid Alcohol/Substance Use

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 34 participants (planned 297)
    • Study completion date changed from estimate of Dec 30, 2026 to Sep 10, 2026
    • Study description expanded, about 6 words
    • Site details revised
  2. Minor Interventions: scale (Other) to case (comorbid diagnosis) (Other), control (Other)v2
  3. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Ostracism
Timeframe: Baseline

Arms and interventions

Case group

Patients will be divided into two groups based on whether or not they have a concomitant diagnosis of Alcohol and Substance Use Disorder (ASUD): (1) Dual diagnosis group (Severe Mental Illness + Alcohol and Substance Use Disorder)

Control group

(2) Control group (Severe Mental Illness, no Alcohol and Substance Use Disorder). The diagnosis of Alcohol and Substance Use Disorder will be determined according to DSM-5 criteria and the recorded diagnosis in the interview and clinical follow-up notes in the community mental health center physician records.

Other: case (comorbid diagnosis), control

Sites

1 site in 1 country

  • Melisa BulutBolu, Bolu, Turkey (Türkiye)